Pacific Capital Wealth Advisors »

Kinnate Biopharma shares owned by Pacific Capital Wealth Advisors

Quarter-by-quarter ownership of Kinnate Biopharma (KNTE) shares owned by Pacific Capital Wealth Advisors from 13F filings

Historical chart of Pacific Capital Wealth Advisors investment in Kinnate Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Kinnate Biopharma held by Pacific Capital Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kinnate Biopharma by Pacific Capital Wealth Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $237 100 2.37

More positions owned by Pacific Capital Wealth Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds Real Estate Etf (VNQ)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Whitehall Fds High Div Yld (VYM)
Schwab Strategic Tr Us Tips Etf (SCHP)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Vanguard Bd Index Fds Intermed Term (BIV)
Ishares Tr Russell 2000 Etf (IWM)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Ishares Tr Ishares Biotech (IBB)
Apple (AAPL)
Schwab Strategic Tr Intl Eqty Etf (SCHF)

View all positions for Pacific Capital Wealth Advisors

Top funds holding Kinnate Biopharma

OrbiMed Advisors
Tang Capital Management
Lynx1 Capital Management
Viking Global Investors
Vanguard Group
Deltec Asset Management
Millennium Management
BML Capital Management
Citadel Advisors
GSA Capital Partners
Two Sigma Investments
Acuitas Investments
Equitec Proprietary Markets
Marshall Wace
Goldman Sachs Group

View all funds holding Kinnate Biopharma